2m 2m 2m 2m 2m 2m 2m
Opko Health (OPK)
NASDAQ
$1.57-$0.005 (-0.32%)
Price as of Sep 11, 2026 7:30 PM EDT- $1.2BMarket Cap
- 12.14%1-Year Change
- Diagnostics & ResearchIndustry
Opko Health (OPK)
$1.57-$0.005 (-0.32%)
OPK | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.57 | ||
Change | +$0.08 (+5.37%) | ||
Open | $1.49 | ||
High | $1.58 | ||
Low | $1.47 | ||
Previous Close | $1.49 | ||
Volume | 5,180,777 | ||
30-Day Average Volume | 2,964,247 | ||
1-Week Change | -4.27% | ||
1-Month Change | 12.95% | ||
1-Year Change | 12.14% | ||
3-Year Change | -8.72% | ||
5-Year Change | -55.90% | ||
Fundamentals | |||
Shares Outstanding | 746.3M | ||
Total Assets | $1.8B | ||
Market Cap | $1.2B | ||
Enterprise Value | $1.3B | ||
Period: QTR TTM FY | |||
Revenue | $74.5M | ||
Net Income | -$8.4M | ||
Free Cash Flow | -$46.5M | ||
EBIT | -$13.4M | ||
EBITDA | $9.0M | ||
Net Working Capital | $350.9M | ||
EPS | -$0.01 | ||
Enterprise Value/EBITDA | 146 | ||
Enterprise Value/Revenue | 18 | ||
P/B | 1 | ||
P/E | -157 | ||
PEG | -2 | ||
Price/Free Cash Flow | -25 | ||
Price/Operating Cash Flow | -27 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue